Previous Article | Next Article 
Molecular and Cellular Biology, September 2006, p. 6333-6346, Vol. 26, No. 17
0270-7306/06/$08.00+0 doi:10.1128/MCB.00207-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Exchange Protein Activated by Cyclic AMP (Epac)-Mediated Induction of Suppressor of Cytokine Signaling 3 (SOCS-3) in Vascular Endothelial Cells
William A. Sands,
Hayley D. Woolson,
Gillian R. Milne,
Claire Rutherford, and
Timothy M. Palmer*
Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow G12 8QQ, United Kingdom
Received 6 February 2006/
Returned for modification 28 March 2006/
Accepted 8 June 2006
Here, we demonstrate that elevation of intracellular cyclic AMP (cAMP) in vascular endothelial cells (ECs) by either a direct activator of adenylyl cyclase or endogenous cAMP-mobilizing G protein-coupled receptors inhibited the tyrosine phosphorylation of STAT proteins by an interleukin 6 (IL-6) receptor trans-signaling complex (soluble IL-6R
/IL-6). This was associated with the induction of suppressor of cytokine signaling 3 (SOCS-3), a bona fide inhibitor in vivo of gp130, the signal-transducing component of the IL-6 receptor complex. Attenuation of SOCS-3 induction in either ECs or SOCS-3-null murine embryonic fibroblasts abolished the inhibitory effect of cAMP, whereas inhibition of SHP-2, another negative regulator of gp130, was without effect. Interestingly, the inhibition of STAT phosphorylation and SOCS-3 induction did not require cAMP-dependent protein kinase activity but could be recapitulated upon selective activation of the alternative cAMP sensor Epac, a guanine nucleotide exchange factor for Rap1. Consistent with this hypothesis, small interfering RNA-mediated knockdown of Epac1 was sufficient to attenuate both cAMP-mediated SOCS-3 induction and inhibition of STAT phosphorylation, suggesting that Epac activation is both necessary and sufficient to observe these effects. Together, these data argue for the existence of a novel cAMP/Epac/Rap1/SOCS-3 pathway for limiting IL-6 receptor signaling in ECs and illuminate a new mechanism by which cAMP may mediate its potent anti-inflammatory effects.
* Corresponding author. Mailing address: 425 Davidson Bldg., Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow G12 8QQ, United Kingdom. Phone: 44 141 330 4626. Fax: 44 141 330 4620. E-mail:
T.Palmer{at}bio.gla.ac.uk.
Molecular and Cellular Biology, September 2006, p. 6333-6346, Vol. 26, No. 17
0270-7306/06/$08.00+0 doi:10.1128/MCB.00207-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Chatterjee, P. K., Al-Abed, Y., Sherry, B., Metz, C. N.
(2009). Cholinergic agonists regulate JAK2/STAT3 signaling to suppress endothelial cell activation. Am. J. Physiol. Cell Physiol.
297: C1294-C1306
[Abstract]
[Full Text]
-
Borland, G., Bird, R. J., Palmer, T. M., Yarwood, S. J.
(2009). Activation of Protein Kinase C{alpha} by EPAC1 Is Required for the ERK- and CCAAT/Enhancer-binding Protein {beta}-dependent Induction of the SOCS-3 Gene by Cyclic AMP in COS1 Cells. J. Biol. Chem.
284: 17391-17403
[Abstract]
[Full Text]
-
Meyers, J. A., Su, D. W., Lerner, A.
(2009). Chronic Lymphocytic Leukemia and B and T Cells Differ in Their Response to Cyclic Nucleotide Phosphodiesterase Inhibitors. J. Immunol.
182: 5400-5411
[Abstract]
[Full Text]
-
Qiao, J., Holian, O., Lee, B.-S., Huang, F., Zhang, J., Lum, H.
(2008). Phosphorylation of GTP dissociation inhibitor by PKA negatively regulates RhoA. Am. J. Physiol. Cell Physiol.
295: C1161-C1168
[Abstract]
[Full Text]
-
Huston, E., Lynch, M. J., Mohamed, A., Collins, D. M., Hill, E. V., MacLeod, R., Krause, E., Baillie, G. S., Houslay, M. D.
(2008). EPAC and PKA allow cAMP dual control over DNA-PK nuclear translocation. Proc. Natl. Acad. Sci. USA
105: 12791-12796
[Abstract]
[Full Text]
-
Qin, H., Niyongere, S. A., Lee, S. J., Baker, B. J., Benveniste, E. N.
(2008). Expression and Functional Significance of SOCS-1 and SOCS-3 in Astrocytes. J. Immunol.
181: 3167-3176
[Abstract]
[Full Text]
-
Narayana, Y., Balaji, K. N.
(2008). NOTCH1 Up-regulation and Signaling Involved in Mycobacterium bovis BCG-induced SOCS3 Expression in Macrophages. J. Biol. Chem.
283: 12501-12511
[Abstract]
[Full Text]
-
Yarwood, S. J., Borland, G., Sands, W. A., Palmer, T. M.
(2008). Identification of CCAAT/Enhancer-binding Proteins as Exchange Protein Activated by cAMP-activated Transcription Factors That Mediate the Induction of the SOCS-3 Gene. J. Biol. Chem.
283: 6843-6853
[Abstract]
[Full Text]
-
Brock, M., Fan, F., Mei, F. C., Li, S., Gessner, C., Woods, V. L. Jr., Cheng, X.
(2007). Conformational Analysis of Epac Activation Using Amide Hydrogen/Deuterium Exchange Mass Spectrometry. J. Biol. Chem.
282: 32256-32263
[Abstract]
[Full Text]
-
Qin, H., Roberts, K. L., Niyongere, S. A., Cong, Y., Elson, C. O., Benveniste, E. N.
(2007). Molecular Mechanism of Lipopolysaccharide-Induced SOCS-3 Gene Expression in Macrophages and Microglia. J. Immunol.
179: 5966-5976
[Abstract]
[Full Text]
-
Fang, Y., Olah, M. E.
(2007). Cyclic AMP-Dependent, Protein Kinase A-Independent Activation of Extracellular Signal-Regulated Kinase 1/2 Following Adenosine Receptor Stimulation in Human Umbilical Vein Endothelial Cells: Role of Exchange Protein Activated by cAMP 1 (Epac1). J. Pharmacol. Exp. Ther.
322: 1189-1200
[Abstract]
[Full Text]
-
Gerdin, M. J., Eiden, L. E.
(2007). Regulation of PC12 Cell Differentiation by cAMP Signaling to ERK Independent of PKA: Do All the Connections Add Up?. Sci Signal
2007: pe15-pe15
[Abstract]
[Full Text]